New York, NY, United States of America

Andrej Zatorski

This inventor holds 1 USPTO granted patent. Top assignees: Columbia University, Sloan-Kettering Institute for Cancer Research. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrej Zatorski: Innovator in Chemical Compounds

Introduction

Andrej Zatorski is a notable inventor based in New York, NY (US). He has made significant contributions to the field of chemistry, particularly in the development of innovative compounds. His work focuses on creating analogues of N-acetylardeemin, which have potential applications in various scientific fields.

Latest Patents

Zatorski holds 1 patent for his invention titled "Analogues of N-acetylardeemin, method of preparation and uses thereof." This patent describes a compound with a complex structure that includes various functional groups. The invention provides methods for inhibiting the growth of multidrug-resistant cells, showcasing its potential in medical applications.

Career Highlights

Throughout his career, Zatorski has worked with prestigious institutions such as the Sloan-Kettering Institute for Cancer Research and Columbia University. His experience in these organizations has allowed him to collaborate with leading experts in the field, enhancing his research and innovation capabilities.

Collaborations

Zatorski has collaborated with notable colleagues, including Samuel J. Danishefsky and Kristopher Depew. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Andrej Zatorski is a distinguished inventor whose work in chemical compounds has the potential to impact various scientific fields. His innovative approach and collaborations with esteemed institutions highlight his contributions to the advancement of technology and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…